Business context and reporting period
Proto Labs, Inc. provides quick-turn custom parts for prototyping and short-run production through injection molding (Protomold), CNC machining (Firstcut), and additive manufacturing (FineLine). This unaudited Form 10-Q covers the quarter and nine months ended September 30, 2014; comparisons are with the corresponding 2013 periods unless otherwise noted. Dollar amounts below are in millions except per-share data.
Financial performance and position
| Metric | Q3 2014 | Q3 2013 | Nine months 2014 | Nine months 2013 |
|---|---|---|---|---|
| Revenue | $54.6 | $42.0 | $153.5 | $119.1 |
| Gross profit / margin | $33.1 / 60.6% | $26.0 / 61.8% | $94.8 / 61.7% | $74.1 / 62.2% |
| Operating income / margin | $15.4 / 28.3% | $13.4 / 31.9% | $45.9 / 29.9% | $37.4 / 31.4% |
| Net income / margin | $10.4 / 19.0% | $8.9 / 21.1% | $31.4 / 20.5% | $25.8 / 21.6% |
| Diluted EPS | $0.40 | $0.34 | $1.20 | $1.00 |
- For the first nine months, operating cash flow was $40.0 million versus $34.9 million. Investing used $55.2 million, including $35.9 million of property and equipment purchases and $33.9 million net cash paid for FineLine; financing provided $6.5 million. Cash declined $8.8 million to $34.3 million.
- At September 30, cash and cash equivalents were $34.3 million and marketable securities totaled $84.7 million. Current assets were $97.6 million and current liabilities $20.1 million. Total debt obligations were $0.2 million; the filing reports no material off-balance-sheet arrangements.
- Total assets were $279.4 million and shareholders’ equity $254.3 million. Goodwill of $28.9 million and net intangible assets of $4.3 million arose from the FineLine acquisition.
Material changes versus prior periods
- Q3 revenue rose 29.9%; nine-month revenue rose 28.9%. Protomold and Firstcut grew 20.7% and 24.7% in Q3, respectively. FineLine contributed $3.4 million in Q3 and $5.5 million year to date; it was acquired in April, so it had no comparable 2013 revenue.
- Management attributed legacy-product growth to more product developers and higher average customer spend, alongside increased sales staffing and marketing. Excluding FineLine purchasers, unique developers increased about 19% in both periods; average revenue per developer rose 2.6% in Q3 and 4.6% year to date.
- Gross margin declined 1.2 percentage points in Q3 and 0.5 points year to date. Management cited FineLine’s lower margins and, for the year-to-date period, the move to a new Plymouth, Minnesota facility. Operating expenses rose 40.5% in Q3 and 33.4% year to date, reflecting higher staffing and growth investment.
- U.S. revenue grew 33.6% in Q3; international revenue grew 20.1%. Currency movements favorably affected international revenue by $0.6 million in Q3 and $1.7 million year to date.
Outlook, risks and unusual items
- No quantified revenue or earnings guidance is provided. Management expects cost of revenue to rise in dollars but remain relatively stable as a share of revenue, and expects continued increases in staffing, marketing, R&D, and G&A investment.
- FineLine consideration included $33.9 million net cash plus contingent consideration initially valued at $3.0 million, tied to 2014 revenue goals and integration milestones. After $0.8 million of payments, $2.2 million remained accrued at September 30. The purchase-price allocation was preliminary; management identified integration, execution, unexpected cost/liability, customer and employee retention, and potential goodwill impairment risks.
- Management reported $0.9 million of liabilities for unrecognized tax benefits and said changes over the next 12 months were expected but could not be estimated. FineLine integration and acquisition-related contingent consideration are notable items; the acquisition’s reported operating contribution was not separately disclosed as material.
- The company has foreign-currency exposure and does not hedge it with forward contracts or currency borrowings. Management estimated a hypothetical 10% adverse exchange-rate change would not materially affect results. It reported no litigation expected to have a material adverse effect.
- Management concluded disclosure controls were effective and reported no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Whether FineLine meets its 2014 revenue and integration milestones, the final acquisition accounting, and any resulting contingent payment or impairment risk.
- Whether growth and customer gains continue while gross margins and operating margins face mix, facility, labor, and expense pressures.
- How substantial capital spending and the FineLine purchase affect cash balances, investment maturities, and future cash generation.
- The effect of foreign exchange movements and unresolved uncertain tax positions on subsequent results.